Recently authorised EU trials

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV

Source: EMA Clinical Trials Information System (CTIS). Showing the 2500 most recently authorised of 12467 total CTIS records — a stated recency window, not the full historical archive. Synced 22 Sep 2026, 03:17 UTC

2500

Shown in this register

most recently authorised

12,467

Total on CTIS

full historical archive

744

Phase III

within the shown window

Top member states

Spain 1018 France 887 Germany 856 Italy 735 Poland 580 Netherlands 527

Narrow the registerReset

Search within results

Phase

Lead sponsor

Clear sponsor filter

Member state

All 28 states

Phase

Study

Lead sponsor

Area

Member states

Decision

Phase I

THERIPEX - A phase I/II open label non-randomized study, monocentric, single-arm, evaluating Safety and Efficacy of induced T-CD4 Treg by LV vector transduction expressing the FoxP3 cDNA in patients with IPEX syndrom

2025-523305-15-00Patients affected by IPEX syndrome, proven by molecular di…

Assistance Publique Hopitaux De Paris

Immune System Diseases

France

24/06/2026

Phase I

CITY

2024-520294-13-00Cutaneous T-cell lymphomas (CTCL)

Assistance Publique Hopitaux De Paris

Skin and Connective Tissue Diseases

Spain, France

26/09/2025

Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-europe

Query this register directly

GET /api/export.php?register=trials-eu&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.